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Abstract
Accumulating evidence suggests that the phenomenon of epithelial-mesenchymal-transition (EMT) plays a
fundamental role in the tumor development. Several research articles have been published from Journal of
Experimental and Clinical Cancer Research (JECCR) which have investigated into the molecular machineries
underlying the importance of EMT for hepatic cancer. Given those recent publications by JECCR, this commentary
focuses on the pathological significance of EMT for liver tumor.
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Commentary
Epithelial-mesenchymal transition (EMT) of cancer cells
indicates the process in which epithelial cells lose their
cell-cell adhesions and apicobasal polarity but also ac-
quire more mesenchymal and invasive/metastatic pheno-
type [1]. While epithelial-typed proteins characterized by
E-cadherin and cytokeratins are down-regulated, mesen-
chymal markers such as vimentin and N-cadherin are
up-regulated. These genetic expression changes are reg-
ulated by EMT-inducing transcriptional factors (TFs)
such as Snail, Slug, Twist, and ZEB1/2 [1]. Twist and
Snail are regulated independently and act cooperatively
to promote EMT of hepatocellular carcinoma (HCC)
[2]. Furthermore, EMT is known to generate stromal-
like cancer cells which acquire the invasion potential
into the extracellular matrix mediated by matrix metal-
loproteinases (MMPs) expression. Xie et al. reported
that the discoidin domain receptor 2 (DDR2) up-
regulates MT1-MMP and MMP2 depending on ERK2/
SNAIL1 axis in HCC [3].
Liver cancer includes primary hepatic neoplasms,
which are distinct from the perspectives of both histo-
logical and molecular pathologies. Hepatic cancer is
mainly classified into HCC, intrahepatic bile duct
carcinoma (cholangiocarcinoma), and hepatoblastoma.
HCC is the most prevalent among these heterogeneous
kinds of hepatic cancer tissues. Chronic infection with
hepatitis B and C virus, long-term alcohol consumption,
aflatoxin-B1-contaminated food and obesity are the
major causes of a late-stage of hepatic fibrosis, also re-
ferred to as cirrhosis [4].
Cirrhosis, composed of numerous regenerative nodules,
leads to the development of HCC. It is sure that the re-
generative nodules at the early stage are benign in nature.
However, they are increasingly likely to transform into the
dysplastic nodules, which correspond to the pre-
malignant conditions [4]. Hepatocytes generally harbor
the rapid cellular proliferation under both normal and in-
flammatory conditions. The rapid rate of cellular division
under pathological conditions such as cirrhosis predis-
poses hepatic stem cells or normal proliferative hepato-
cytes to accumulate genetic and epigenetic alterations.
Still, it remains to be unknown whether the origin of HCC
is hepatic stem cells or differentiated hepatocytes.
The molecular analysis of human HCC specimens has
elucidated many genetic and epigenetic changes character-
ized by TP53, beta-catenin, E-cadherin, MET and its lig-
and hepatocyte growth factor, ErbB receptor family
members, and cyclooxygenase 2 (COX2) [4]. Beta-catenin
is a crucial downstream TF of the canonical Wnt signal
pathway. When Wnt signal pathway is activated, Axin and
adenomatous polyposis coli (APC) no longer bind to beta-
catenin, resulting in the stabilization and the intra-nuclear
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translocation of the dissociated beta-catenin. Increased
nuclear localization of beta-catenin has been frequently
detected in human HCC samples [4, 5]. Wnt/beta-catenin
signaling pathway regulates several genes governing
cancer-relevant processes, including MYC, cyclin D1,
COX2, and MMP7 [5]. Notably, Tang et al. have recently
identified CTNND1 (delta-catenin) as a novel oncogene
in HCC. The expression level of CTNND1 is positively
correlated with invasiveness in human HCC specimens,
and further, activates Wnt/beta-catenin signaling. Knock-
down of CTNND1 expression surprisingly leads to
mesenchymal-epithelial transition (MET), while overex-
pression results in EMTand enhances metastatic potential
of HCC [6].
Du et al. revealed that Brachyury, which is highly con-
served through evolution, promotes EMT of HCC via
activation of Akt/mTOR signal pathway [7]. Brachyury
belongs to the TFs within T-box and contributes to the
formation of the midline of a bilaterian organism. Bra-
chyury is expressed not only in the progenitor popula-
tion throughout somitogenesis but also multiple types of
human cancer such as lung and liver. Brachyury has
been identified as an essential EMT regulator altering
the expression level of E-cadherin and Slug [7]. In par-
ticular, there is the positive feedback machinery between
Brachyury and TGF-beta in mesenchymal-like tumor
cells, which have undergone EMT and up-regulated Bra-
chyury [8]. Brachyury-overexpressed HCC cell lines
undergo EMT with Akt activation, therefore promoting
the metastasis, particularly the process of extravasation,
colonization and the proliferation at the pre-metastatic
niche [7].
Remarkably, EMT also contributes to the increased
population of cancer stem-like cells (CSCs), which corre-
sponds to the highly tumorigenic subpopulation of
tumor cells existing at the top of the hierarchical tumor
cell society [1, 9]. The enhanced emergence of CSCs due
to EMT is expected to be responsible for tumor hetero-
geneity and therapeutic resistance [9]. For instance,
Zhang et al. have recently demonstrated that the resist-
ance to FOLFOX, the conventional anti-HCC chemo-
therapeutic regimen, is positively correlated with nestin
expression, which leads to EMT and the increased num-
ber of CSCs associated with Wnt/beta-catenin activation
[10]. Collectively, accumulating evidence has strongly
suggested that the emerging roles of potentially thera-
peutic targets should be regarded as “silver bullets”
against difficult-to-cure HCC cases.
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